Krzysztof W Selmaj

7PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesMedical virologyMemory and attentionCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 03, 2026
A new, glycoengineered form of anti-CD20 monoclonal antibody, in treatment of multiple sclerosis.

Krzysztof Selmaj, Ralf Gold, Igor Selmaj

|Mar 31, 2026
Novel homozygous SYNE1 missense variant in late onset autosomal recessive cerebellar ataxia 1: a case report.

Igor Selmaj, Nastassja Himmelreich, Krzysztof Selmaj

|Mar 27, 2026
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants.

Ralf Gold, Krzysztof W Selmaj, Regina Berkovich

|Mar 10, 2026
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study.

Bruno Brochet, Dawn Langdon, Eva Kubala Havrdova

|Aug 13, 2021
Multiple Sclerosis: circRNA Profile Defined Reveals Links to B-Cell Function.

Anna E Zurawska, Marcin P Mycko, Igor Selmaj

|Oct 31, 2019
Novel emerging treatments for NMOSD.

Krzysztof Selmaj, Igor Selmaj

Pageof 2

Frequent Collaborators

2 joint publications

Bruno Brochet

2 joint publications

Dawn Langdon

2 joint publications

Eva Kubala Havrdova

2 joint publications

Jeanette Lechner-Scott